TY - JOUR
T1 - Preparation of mouse-human chimeric antibody to an embryonic carbohydrate antigen, Lewis Y
AU - Kaneko, Takashi
AU - Iba, Yoshitaka
AU - Zenita, Koichi
AU - Shigeta, Katsuyoshi
AU - Nakano, Eoichi
AU - Itoh, Wataru
AU - Kurosawa, Yoshikazu
AU - Kannagi, Reiji
AU - Yasukawa, Klyoshi
PY - 1993/1
Y1 - 1993/1
N2 - Stage-specific embryonic antigen-1 (SSEA-1) is a well-known carbohydrate antigen that is specifically expressed on the surface of cancer cells as well as embryonic cells. In this study, starting with a previously established hybridoma producing a monoclonal antibody (named H18A) to Lewis Y antigen, which is closely related to SSEA-1, we cloned genomic DNA encoding active variable regions both of heavy and light chains of the antibody. Sequence analysis showed that VH and Vr genes of H18A were in the VH7183 family and V Cl family, respectively. A transfected cell line named HC-H18A-7 expressing a recombinant chimeric H18A composed of mouse-derived antigen-binding variable regions and humanderived constant regions was established. The chimeric H18A was purified to homogeneity and shown to bind purified Lewis Y antigen with the same dose-response curve as the original H18A. The chimeric H18A looks more promising for clinical application than the original mouse-derived H18A because its antigenicity is expected to be reduced. 1993
AB - Stage-specific embryonic antigen-1 (SSEA-1) is a well-known carbohydrate antigen that is specifically expressed on the surface of cancer cells as well as embryonic cells. In this study, starting with a previously established hybridoma producing a monoclonal antibody (named H18A) to Lewis Y antigen, which is closely related to SSEA-1, we cloned genomic DNA encoding active variable regions both of heavy and light chains of the antibody. Sequence analysis showed that VH and Vr genes of H18A were in the VH7183 family and V Cl family, respectively. A transfected cell line named HC-H18A-7 expressing a recombinant chimeric H18A composed of mouse-derived antigen-binding variable regions and humanderived constant regions was established. The chimeric H18A was purified to homogeneity and shown to bind purified Lewis Y antigen with the same dose-response curve as the original H18A. The chimeric H18A looks more promising for clinical application than the original mouse-derived H18A because its antigenicity is expected to be reduced. 1993
UR - http://www.scopus.com/inward/record.url?scp=0027399442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027399442&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.jbchem.a123993
DO - 10.1093/oxfordjournals.jbchem.a123993
M3 - Article
C2 - 8095932
AN - SCOPUS:0027399442
VL - 113
SP - 114
EP - 117
JO - Journal of Biochemistry
JF - Journal of Biochemistry
SN - 0021-924X
IS - 1
ER -